Check out the FULL program for the 27th Annual Meeting, May 7-11, online or print the PDF!
The American Society of Gene and Cell Therapy will award a total of $900,000 in 2023 in support of members developing their careers.
ASGCT will award a $100,000 Career Development Award in each of the following six broad topics (six total grants):
Viral Vector Development
Gene Targeting and Gene Correction
Oligonucleotide Therapeutics
Cell Therapies
Immunological Aspects of Gene Therapy and Vaccines
Synthetic/Molecular Conjugates and Physical Methods for Delivery of Gene Therapeutics
Additionally, in 2023, ASGCT has partnered with the Children's Tumor Foundation (CTF). As part of a shared mission to drive scientific research and funding, the Children's Tumor Foundation is supporting three additional $100,000 Career Development Awards that may impact neurofibromatosis and schwannomatosis. CTF has provided this presentation on neurofibromatosis for informational purposes.
Overview & Benefits Required Documents
The purpose of these awards is to support independent transformative pilot studies in gene and cell therapy by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms. ASGCT is interested in helping applicants generate their own independent preliminary data to use in larger proposals (NIH K awards, first-submission R-level funding, etc.) to gain independence. Learn more about the eligibility requirements, application materials, and key deadlines in the Career Development Award Overview and Benefits.
*The CDAs are supported in 2023 by the Children's Tumor Foundation without any influence on the content of the program or selection of the award recipients. Learn more about opportunities to support this program.
Any ASGCT member type who is in good standing, and persons who have a membership application pending may apply. To verify your membership status, please log in to your ASGCT account.
Not an ASGCT member yet? Take the first step. Submit your membership application at least 5 business days prior to the application deadline to allow sufficient time for processing. The mentor is not required to be an ASGCT member.
Each $100,000 award must be used during the budget period of November 2022 – December 2023. All funds must be used for direct expenses associated with conducting the proposed project, and are non-transferable. It can include personnel and travel where those expenses are directly related to the project. ASGCT considers salary, where it is directly attributed to the sponsored project and meets all other criteria, a direct cost. Please refer to our Grant Policy Statement for a list of accepted costs.
U.S. citizenship is not required but both the applicant and mentor must be located in the United States during the duration of the research. Any visa and/or citizenship restrictions applicable to receiving the award are the responsibility of the applicant.
Yes.
Winners will be notified on November 15 and will receive their awards on November 30.
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico